Skip to main content

Maternal antibodies do not interfere with VEPURED® efficacy

Publications
Swine
Authors

Simon-Grifé, M.; Mallorquí, J.; Ferrer-Soler, L.; Roca, M.; Saün, X.; Sitjà, M.

Appeared in

ESPHM Congress, 2017

VEPURED® efficacy was clearly demonstrated in the presence of field representative MDAs.

Appeared in: ESPHM Congress, 2017
Authors: Simon-Grifé, M.; Mallorquí, J.; Ferrer-Soler, L.; Roca, M.; Saün, X.; Sitjà, M.

VEPURED® is a vaccine developed to protect piglets against edema disease (ED) from 2 days of age, even when maternally derived antibodies (MDAs) could still be present.

Download this article
PDF